Loading...
Loading...
India's diclofenac imports from UNITED STATES total $13.4M across 306 shipments from 15 foreign suppliers. ACTAVIS LABORATORIES FL INC leads with $13.1M in import value; the top 5 suppliers together control 99.4% of this origin. Leading Indian buyers include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for diclofenac — a diversified sourcing base with multiple active suppliers from UNITED STATES.

ACTAVIS LABORATORIES FL INC is the leading Diclofenac supplier from UNITED STATES to India, with import value of $13.1M across 3 shipments. The top 5 suppliers — ACTAVIS LABORATORIES FL INC, ESPEE BIOPHARMA & FINECHEM LLC, AMNEAL PHARMACEUTICALS, LLC, AMNEAL LLC, NEW LIFE MEDICALS LLC.. — collectively account for 99.4% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ACTAVIS LABORATORIES FL INC | $13.1M | 3 | 97.8% |
| 2 | ESPEE BIOPHARMA & FINECHEM LLC | $109.3K | 4 | 0.8% |
| 3 | AMNEAL PHARMACEUTICALS, LLC | $53.3K | 140 | 0.4% |
| 4 | AMNEAL LLC | $29.1K | 26 | 0.2% |
| 5 | NEW LIFE MEDICALS LLC.. | $24.5K | 2 | 0.2% |
| 6 | ACTAVIS LABORATORIES FL INC. | $10.6K | 13 | 0.1% |
| 7 | AMNEAL PHARMACEUTICALS LLC | $10.3K | 42 | 0.1% |
| 8 | ESPEE BIOPHARMA AND FINECHEM LLC | $6.9K | 1 | 0.1% |
| 9 | AGRACE PHARMA, | $6.6K | 2 | 0.0% |
| 10 | AUROBINDO PHARMA USA, INC | $6.4K | 2 | 0.0% |
| 11 | BILCARE GCS INC | $6.3K | 7 | 0.0% |
| 12 | ACTAVIS ELIZABETH LLC | $4.9K | 10 | 0.0% |
| 13 | RAFF & HALL PHARMACY, | $4.5K | 1 | 0.0% |
| 14 | ESPEE BIOPHARMA FINECHEM LLC | $2.8K | 3 | 0.0% |
| 15 | SPRING BIO SOLUTION | $2.0K | 1 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $13.2M | 24 | 97.9% |
| 2 | ENCUBE ETHICALS PRIVATE LIMITED | $106.3K | 1 | 0.8% |
| 3 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $96.3K | 238 | 0.7% |
| 4 | UMEDICA LABORATORIES PRIVATE LIMITED | $35.9K | 11 | 0.3% |
| 5 | AUROBINDO PHARMA LTD | $9.3K | 7 | 0.1% |
| 6 | ALEMBIC PHARMACEUTICALS LIMITED | $7.8K | 2 | 0.1% |
| 7 | UNICHEM LABORATORIES LIMITED | $6.6K | 2 | 0.0% |
| 8 | ZYDUS HEALTHCARE LIMITED | $4.5K | 1 | 0.0% |
| 9 | MICRO LABS LIMITED | $2.3K | 2 | 0.0% |
| 10 | AJANTA PHARMA LIMITED | $2.2K | 5 | 0.0% |
| 11 | ENCUBE ETHICALS PVT LTD | $2.0K | 1 | 0.0% |
| 12 | UMEDICA LABORATORIES PVT LTD | $1.7K | 2 | 0.0% |
| 13 | G7 SYNERGON PRIVATE LIMITED | $1.2K | 1 | 0.0% |
| 14 | MACLEODS PHARMACEUTICALS LTD | $805 | 2 | 0.0% |
| 15 | ACTAVIS PHARMA DEVELOPMENT CENTRE PVT.LTD. | $577 | 2 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Diclofenac suppliers from UNITED STATES to India include ACTAVIS LABORATORIES FL INC, ESPEE BIOPHARMA & FINECHEM LLC, AMNEAL PHARMACEUTICALS, LLC. The leading supplier is ACTAVIS LABORATORIES FL INC with import value of $13.1M USD across 3 shipments. India imported Diclofenac worth $13.4M USD from UNITED STATES in total across 306 shipments.
India imported Diclofenac worth $13.4M USD from UNITED STATES across 306 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Diclofenac sourced from UNITED STATES include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED, ENCUBE ETHICALS PRIVATE LIMITED, AMNEAL PHARMACEUTICALS PRIVATE LIMITED. The largest buyer is ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED with $13.2M in imports across 24 shipments.
The total value of Diclofenac imports from UNITED STATES to India is $13.4M USD, across 306 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
306 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists